matt bodner is there with the latest today hello, matt. >> good evening. it's the first to market this is very clearly the message the government wants us to hear in naming it sputnik there are a lot of questions that remain. it's important to note this vaccine has only been through phase 1 and phase 2 trials officially in a clinical setting, maybe about 100 people maximum have actually been injected with this thing that has not stopped them from moving ahead with production possibly the best thing to think about what's going on here today, what we've learned today, is russia is essentially just moving forward with its phase 3 trials and doing them live while they're starting to ramp up production, the first group of people who will get it is probably about a thousand dr doctors and medical professionals who will be close at hand. what we haven't seen is the long-term effects of the vaccine. nobody really knows and even what we've seen so far hasn't been published yesterday a lot of concerns even here within russia. yesterday an association of critical tes